AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
164.77
+3.14 (1.94%)
At close: Sep 3, 2026, 4:00 PM EDT
163.33
-1.44 (-0.87%)
Pre-market: Sep 4, 2026, 8:49 AM EDT
AstraZeneca Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, AstraZeneca stock has a consensus rating of "Strong Buy" and an average price target of $212.54. The average 1-year stock price forecast is 28.99% higher than the current stock price, while the lowest is $184 (+11.67%) and the highest is $240 (+45.66%).
Price Target: $212.54 (+28.99%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AstraZeneca stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 7 | 7 | 6 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 1 | 1 | 1 | 1 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains $237 | Buy | Maintains | $237 | +43.83% | Aug 28, 2026 |
| Deutsche Bank | Deutsche Bank | Sell Maintains $156 | Sell | Maintains | $156 | -5.48% | Aug 25, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Initiates $198 | Buy | Initiates | $198 | +20.17% | Aug 24, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $218 → $221 | Buy | Maintains | $218 → $221 | +33.96% | Aug 20, 2026 |
| UBS | UBS | Buy Maintains $238 | Buy | Maintains | $238 | +44.65% | Aug 19, 2026 |
Financial Forecast
Revenue This Year
63.24B
from 58.74B
Increased by 7.66%
Revenue Next Year
66.82B
from 63.24B
Increased by 5.66%
EPS This Year
10.26
from 9.16
Increased by 11.97%
EPS Next Year
11.42
from 10.26
Increased by 11.33%
EPS and Forward PE are based on non-GAAP adjusted numbers.